Story thread · 2 reports / 1 sources

Novartis (NVS) Suffers its Third Drug Trial Setback in a Week, and its Worst Trading Day in Years

finance.yahoo.com · 1d

Novartis (NVS) Suffers its Third Drug Trial Setback in a Week, and its Worst Trading Day in Years

First report: Novartis (NVS) and Ionis (IONS)’ Big Cholesterol Bet Comes Up Short in Late-Stage Trial finance.yahoo.com, 1d

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.